ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
154 hedge funds and large institutions have $157M invested in Antares Pharma, Inc. in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $312M → $157M (-$155M)
58% less call options, than puts
Call options by funds: $262K | Put options by funds: $628K
Holders
154
Holding in Top 10
2
Calls
$262K
Puts
$628K
Top Buyers
| 1 | +$2.36M | |
| 2 | +$2.04M | |
| 3 | +$1.27M | |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$1.2M |
| 5 |
JP Morgan Chase
New York
|
+$1.11M |
Top Sellers
| 1 | -$6.36M | |
| 2 | -$3.44M | |
| 3 | -$2.55M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.28M |
| 5 |
Goldman Sachs
New York
|
-$1.18M |